Skip to main content
. Author manuscript; available in PMC: 2024 Jun 17.
Published in final edited form as: Ann Thorac Surg. 2023 Jan 22;115(5):1162–1170. doi: 10.1016/j.athoracsur.2022.12.041

TABLE 1.

Baseline Characteristics Stratified by Tricuspid Repair vs Replacement and Beating Heart vs Full Arrest Operations

Characteristics All Patients
(N = 6507)
Repair
(n = 3308)
Replacement
(n = 3199)
P Value Beating Heart
(n = 2435)
Full Arrest
(n = 3901)
P Value
Age, y 65 (52-74) 65 (51-74) 66 (53-74) .42 68 (57-75) 63 (49-73) <.001
Male sex 38.5 (2507) 39.0 (1290) 38.4 (1217) .43 39.8 (969) 37.8 (1475) .11
Body mass index, kg/m2 26.9 (23.4-31.3) 27.1 (23.7-31.5) 26.8 (23.3-31.2) .06 26.9 (23.6-31.2) 27.0 (23.4-31.4) .92
White race 77.6 (5047) 77.5 (2562) 77.7 (2485) .20 77.9 (1898) 77.4 (3018) .16
Diabetes 23.6 (1537) 22.2 (733) 25.1 (804) .005 27.3 (665) 21.0 (823) <.001
Dialysis dependency 4.7 (307) 4.8 (157) 4.7 (150) .91 6.2 (149) 3.9 (152) <.001
Chronic lung disease 26.7 (1742) 25.3 (837) 28.3 (905) .007 30.2 (736) 24.7 (962) <.001
Liver disease 14.5 (940) 10.3 (339) 18.8 (601) <.001 17.8 (434) 12.5 (486) <.001
Peripheral vascular disease 7.3 (476) 6.9 (229) 7.7 (247) .22 9.4 (229) 6.0 (232) <.001
Cerebrovascular disease 15.4 (1003) 15.1 (498) 15.8 (505) .41 18.9 (460) 13.3 (518) <.001
Atrial fibrillation 47.1 (3062) 47.0 (1555) 47.1 (1507) .93 51.3 (1250) 44.3 (1729) <.001
Previous myocardial infarction 10.0 (648) 10.0 (330) 9.9 (318) .96 13.5 (329) 7.7 (299) <.001
Left ventricular ejection fraction, % 58 (52-60) 58 (53-61) 58 (52-60) .16 56 (50-60) 58 (53-62) <.001
New York Heart Association class III/IV heart failure 40.0 (2599) 34.7 (1149) 45.3 (1450) <.001 51.09 (1244) 33.1 (1290) <.001
Previous cardiac surgery 41.3 (2686) 32.4 (1072) 50.5 (1614) <.001 59.0 (1436) 29.0 (1132) <.001
Previous tricuspid valve surgery 8.4 (548) 2.0 (66) 15.1 (482) <.001 10.3 (250) 7.1 (278) <.001
Creatinine (mg/dL) 1.0 (0.8-1.3) 1.0 (0.8-1.2) 1.0 (0.8-1.4) <.001 1.1 (0.9-1.5) 1.0 (0.8-1.2) <.001
Total bilirubin (mg/dL) 0.8 (0.5-1.2) 0.8 (0.5-1.1) 0.9 (0.6-1.3) <.001 0.9 (0.6-1.3) 0.8 (0.5-1.2) <.001
Model for end-stage liver disease 10.1 (7.5-13.7) 9.4 (7.5-12.9) 10.7 (8.4-14.3) <.001 11.1 (8.4-15.3) 9.3 (7.5-12.6) <.001

Values are in % (n) or median (interquartile range).